Keir Loiacono
Chief Executive Officer presso BlueSphere Bio, Inc.
Profilo
Keir Loiacono is currently the Chief Executive Officer at BlueSphere Bio, Inc. and also serves as a Director at EpiAxis Therapeutics Pty Ltd.
Previously, he worked as the Chief Compliance Officer & Vice President-Legal at OncoSec Medical, Inc. and as the Head-Legal at Advaxis, Inc. Mr. Loiacono completed his undergraduate degree at Manhattan College and his graduate degree at Pace Law School.
Posizioni attive di Keir Loiacono
Società | Posizione | Inizio |
---|---|---|
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Chief Executive Officer | 04/10/2022 |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Director/Board Member | - |
Precedenti posizioni note di Keir Loiacono
Società | Posizione | Fine |
---|---|---|
AYALA PHARMACEUTICALS, INC. | General Counsel | - |
ONCOSEC MEDICAL INCORPORATED | Compliance Officer | - |
Formazione di Keir Loiacono
Manhattan College | Undergraduate Degree |
Pace Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
Aziende private | 3 |
---|---|
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Keir Loiacono